Febarbamate
Chemical compound
- M03BA05 (WHO)
- [1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-
diazinan-1-yl)propan-2-yl] carbamate
- 13246-02-1
Y
- 25803
- 24039 Y
- 5Z48ONN38P
- D07275 Y
- ChEMBL2104283
N
- Interactive image
- C1(=O)NC(C(C(=O)N1CC(OC(=O)N)COCCCC)(C2=CC=CC=C2)CC)=O
InChI
- InChI=1S/C20H27N3O6/c1-3-5-11-28-13-15(29-18(21)26)12-23-17(25)20(4-2,16(24)22-19(23)27)14-9-7-6-8-10-14/h6-10,15H,3-5,11-13H2,1-2H3,(H2,21,26)(H,22,24,27)Y
- Key:QHZQILHUJDRDAI-UHFFFAOYSA-NY
N
Y (what is this?) (verify)Febarbamate (INN; Solium, Tymium), also known as phenobamate, is an anxiolytic and tranquilizer of the barbiturate and carbamate families which is used in Europe by itself and as part of a combination drug formulation called tetrabamate.[1][2][3][4]
See also
References
- ^ World Health Organization (2004). "The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance" (PDF).
- ^ Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 427. ISBN 978-3-88763-075-1. Retrieved 26 November 2011.
- ^ Gentili E (March 1972). "[Therapeutic effects of a new psycholeptic agent (febarbamate, Solium) in pediatrics]". Minerva Medica (in Italian). 63 (18): 1058–60. PMID 5016064.
- ^ Morton I, Hall JM (1999). Concise dictionary of pharmacological agents: properties and synonyms. Springer. p. 118. ISBN 978-0-7514-0499-9. Retrieved 26 November 2011.
- v
- t
- e
Skeletal muscle relaxants (M03)
(primarily antinicotinic,
NMJ block)
| Non-depolarizing |
| ||||
|---|---|---|---|---|---|
| Depolarizing |
| ||||
| ACh release inhibitors |
 | This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
